Latest

Latest monoclonal antibodies News | Page 2

Latest monoclonal antibodies news stories and updates. What is happening today? All recent monoclonal antibodies news and developments. Live coverage and timeline of monoclonal antibodies. All you need to know about monoclonal antibodies.

14 Oct 2022 3:39 pm AEST

New Omicron subvariant largely evades neutralizing antibodies

20 Sep 2022 4:03 pm AEST

Evusheld long-acting antibody combination approved in EU for treatment of Covid

16 Sep 2022 4:09 pm AEST

Evusheld long-acting antibody combination recommended for approval in EU for treatment of Covid

16 Sep 2022 4:06 pm AEST

Beyfortus recommended for approval in EU by CHMP for prevention of RSV lower respiratory tract disease in infants

30 Aug 2022 10:03 pm AEST

Evusheld long-acting antibody combination approved for prevention and treatment of Covid in Japan

23 Aug 2022 5:57 pm AEST

RSV prevention finally in reach after 20 years of research at Telethon Kids Institute

19 Aug 2022 6:51 pm AEST

WHO makes new recommendations for Ebola treatments, calls for improved access

22 Jun 2022 10:03 pm AEST

Lack of innovation set to undermine antibiotic performance and health gains

17 May 2022 4:06 pm AEST

AstraZeneca signs licence agreement with RQ Biotechnology for monoclonal antibodies against Covid

7 Apr 2022 2:30 pm AEST

TGA receives application for an increased dose of GlaxoSmithKline’s Covid treatment sotrovimab for BA.2 Omicron sublineage

28 Mar 2022 11:33 pm AEST

Promising nose spray could prevent and treat Covid

18 Mar 2022 12:54 am AEST

AstraZeneca’s antibody combination, Evusheld▼ authorised for use

15 Mar 2022 10:48 am AEST

New hope for babies born with heart defect

10 Mar 2022 8:33 am AEST

Sotrovimab shown to cause Covid treatment-resistant mutations

25 Feb 2022 3:45 pm AEST

AstraZeneca’s Evusheld Granted Provisional Approval For Pre-Exposure Prophylaxis Of Covid

25 Feb 2022 11:45 am AEST

TGA provisionally approves AstraZeneca’s combination therapy – for pre-exposure prevention of Covid

17 Feb 2022 11:03 pm AEST

Nirsevimab EMA regulatory submission accepted under accelerated assessment for RSV protection in all infants

3 Feb 2022 11:57 pm AEST

Study Reveals How Migraine Pain Signals Are Generated-and Blocked

27 Jan 2022 11:45 pm AEST

Researchers Identify Osteoarthritis ‘Pain Pathway’

14 Jan 2022 6:39 pm AEST

WHO recommends two new drugs to treat Covid

4 Jan 2022 3:57 pm AEST

TGA grants provisional determination to AstraZeneca Pty Ltd for Covid prophylaxis and treatment, tixagevimab and cilgavimab

23 Dec 2021 5:03 pm AEST

Evusheld long-acting antibody combination retains neutralising activity against Omicron variant 23 December

17 Dec 2021 12:03 am AEST

Evusheld long-acting antibody combination retains neutralising activity against Omicron variant

9 Dec 2021 7:03 am AEST

Evusheld long-acting antibody combination authorised for emergency use

18 Nov 2021 5:09 pm AEST

New analyses of two AZD7442 Covid Phase III trials in high-risk populations confirm robust efficacy and long-term prevention

9 Nov 2021 3:06 pm AEST

TGA grants provisional determination to AstraZeneca Pty Ltd for Covid preventative treatment, tixagevimab and cilgavimab

19 Oct 2021 8:06 am AEST

CSL Research and Development Day 2021

19 Oct 2021 7:18 am AEST

Research-industry partnership to advance biologic therapies

17 Oct 2021 7:33 pm AEST

Australia secures additional Covid treatments

5 Oct 2021 4:03 pm AEST

AZD7442 request for Emergency Use Authorization for Covid prophylaxis filed in US

1 Oct 2021 2:12 pm AEST

Researchers Illuminate Working Mechanism of Important Drug Target Proteins

1 Oct 2021 8:00 am AEST

WHO prioritizes access to diabetes and cancer treatments in new Essential Medicines Lists

29 Sep 2021 8:48 am AEST